​

Standard BioTools (LAB) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

LAB Stock Forecast

Standard BioTools (LAB) stock forecast, based on 3 Wall Street analysts, predicts a 12-month average price target of $3.25, with a high of $3.25 and a low of $3.25. This represents a 105.70% increase from the last price of $1.58.

High: $3.25 Avg: $3.25 Low: $3.25 Last Closed Price: $1.58

LAB Stock Rating

Standard BioTools stock's rating consensus is Buy, based on 3 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 3 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 3 0 3 Strong Sell Sell Hold Buy Strong Buy

LAB Forecast vs Benchmarks

TypeNameUpside
StockStandard BioTools105.70%
SectorHealthcare Stocks 25.20%
IndustryDiagnostics & Research Stocks16.01%

Price Target Trends

1M3M12M
# Anlaysts--1
Avg Price Target--$3.25
Last Closing Price$1.58$1.58$1.58
Upside/Downside--105.70%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 25-3---3
Dec, 24-3---3
Nov, 2413---4
Oct, 2413---4
Sep, 2413---4
Latest Price Target by Analysts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Apr 04, 2024Matthew StantonJefferies$3.25$2.6622.18%105.70%
Latest Upgrade/Downgrade by Analysts
DateCompanyPrevious RatingNew RatingRating Change
Sep 16, 2024Cowen & Co.BuyBuyhold
Apr 16, 2024Cowen & Co.Buyinitialise
Apr 04, 2024JefferiesBuyinitialise
Jul 12, 2023KeyBancOverweightinitialise

Financial Forecast

EPS Forecast

Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-0.74$-0.78$-2.43$-0.94----
Avg Forecast$-0.55$-0.94$-1.00$-0.94$-0.36$-0.20$-0.08$-0.04
High Forecast$-0.57$-0.96$-1.02$-0.97$-0.37$-0.21$-0.08$-0.04
Low Forecast$-0.54$-0.91$-0.99$-0.91$-0.35$-0.19$-0.07$-0.04
Surprise %34.55%-17.02%143.00%-----

Revenue Forecast

$50M $100M $150M $200M $250M $300M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$138.14M$130.58M$97.95M$106.34M----
Avg Forecast$144.27M$125.00M$124.40M$103.00M$171.20M$186.93M$224.21M$252.70M
High Forecast$141.27M$122.40M$123.23M$101.33M$167.39M$184.79M$216.32M$247.07M
Low Forecast$146.95M$127.33M$126.43M$104.67M$175.91M$189.08M$232.11M$259.65M
Surprise %-4.24%4.46%-21.26%3.24%----

Net Income Forecast

$-200M $-160M $-120M $-80M $-40M $0 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-53.02M$-59.24M$-190.10M$-74.66M----
Avg Forecast$-43.83M$-74.41M$-79.16M$-74.66M$-28.33M$-15.89M$-6.08M$-3.18M
High Forecast$-44.89M$-76.21M$-80.84M$-77.07M$-29.24M$-16.40M$-6.27M$-3.28M
Low Forecast$-42.64M$-72.40M$-78.19M$-72.26M$-27.42M$-15.37M$-5.88M$-3.07M
Surprise %20.98%-20.39%140.14%-----

LAB Forecast FAQ

Is Standard BioTools stock a buy?

Standard BioTools stock has a consensus rating of Buy, based on 3 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 3 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Standard BioTools is a favorable investment for most analysts.

What is Standard BioTools's price target?

Standard BioTools's price target, set by 3 Wall Street analysts, averages $3.25 over the next 12 months. The price target range spans from $3.25 at the low end to $3.25 at the high end, suggesting a potential 105.70% change from the previous close price of $1.58.

How does Standard BioTools stock forecast compare to the average forecast of its sector, industry, and investment themes?

Standard BioTools stock forecast shows a 105.70% upside, outperforming the average forecast for the healthcare stocks sector (25.20%) and outperforming the diagnostics & research stocks industry (16.01%).

What is the breakdown of analyst ratings for Standard BioTools over the past three months?

  • January 2025: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • December 2024: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • November 2024: 25.00% Strong Buy, 75.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Standard BioTools’s EPS forecast?

Standard BioTools's average annual EPS forecast for its fiscal year ending in December is -0.36 for 2024, a -61.70% decrease from the reported $-0.94 in 2023. The prediction for 2025 is $-0.2, $-0.08 for 2026, and $-0.04 for 2027.

What is Standard BioTools’s revenue forecast?

Standard BioTools's average annual revenue forecast for its fiscal year ending in December is $171.2M for 2024, a 60.99% increase from the reported $106.34M in 2023. The forecast for 2025 is $186.93M, $224.21M for 2026, and $252.7M for 2027.

What is Standard BioTools’s net income forecast?

For its fiscal year ending in December, Standard BioTools's average annual net income forecast is $-28.33M for 2024, reflecting a -62.05% decrease from the reported $-74.656M in 2023. The projection for 2025 is $-15.886M, $-6.076M for 2026, and $-3.177M for 2027.